20146 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
Sub-classes:HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
#2SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#3Method For Treatment Of Pancreatic Cancer
#4CANNABINOID COMPOSITIONS FOR VIRTUAL AND AUGMENTED REALITY EXPERIENCES
#5HYDROGEL DRUG DELIVERY IMPLANTS
#6COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING MATERIALS FOR FOLLICULAR DELIVERY
#7PERITONEAL DETERIORATION INHIBITING COMPOSITION, PERITONEAL DETERIORATION INHIBITING COMPOSITION KIT, PERITONEAL DIALYSATE, PERITONEAL DIALYSATE KIT
#8FORMULATIONS OF VILOXAZINE
#9HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS
#10FORMULATIONS FOR ADMINISTERING LAAM, norLAAM AND dinorLAAM AND METHODS OF THEIR USE TO TREAT OPIOID USE DISORDER
#11IgY Antibody Compositions and Methods for Treating Mammal Species
#12PURIFIED EXOSOME PRODUCTS, METHOD OF MAKING, AND METHODS OF USING
#13PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS
#14MICROPARTICLES CONTAINING BUPROPION
#15FORMULATIONS OF VILOXAZINE
#16FORMULATIONS OF VILOXAZINE
#17ENCAPSULATED GAS OR PARTIAL VACUUM CONTRAST MATERIAL
#18USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#19PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#20COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
#21THERAPEUTICS AND METHOD FOR TREATING OSTEOARTHRITIS
#22METHODS AND DEVICES FOR PREPARATION OF ULTRASOUND CONTRAST AGENTS
#23THERAPEUTICS AND METHOD FOR TREATING OSTEOARTHRITIS
#24COMPOSITION HAVING EFFECTS OF PROTECTING EYES AND IMPROVING EYESIGHT AND USE THEREOF IN FIELD OF PREPARING FOOD OR MEDICINE
#25ACYL NORNICOTINES REDUCE SENSORY IRRITATION IN TOBACCO AND NICOTINE PRODUCTS
#26SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#27COLON LAVAGE SYSTEM
#28Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#29DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
#30PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
#31GRANULE COMPRISING ENCAPSULATED ACTIVE INGREDIENTS
#32USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#33LIQUID DOSAGE FORMS OF SODIUM NAPROXEN
#34PURIFIED EXOSOME PRODUCTS, METHOD OF MAKING, AND METHODS OF USING
#35STABLE EMULSIONS AND METHODS
#36ENCAPSULATED GAS OR PARTIAL VACUUM CT CONTRAST MATERIAL
#37CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#38SYNERGISTIC CANNABINOID ESTERS, THEIR SALTS AND USES THEREOF
#39METHODS OF IMPROVING NEURODEGENERATIVE DISORDERS BY TARGETED DELIVERY OF THERAPEUTIC AGENTS
#40CANNABINOID COMPOSITIONS FOR VIRTUAL AND AUGMENTED REALITY EXPERIENCES
#41METHODS OF IMPROVING NEURODEGENERATIVE DISORDERS BY TARGETED DELIVERY OF THERAPEUTIC AGENTS
#42USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#43METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#44METHODS AND COMPOSITIONS FOR CANNABINOID-BASED THERAPEUTICS
#45COMPOSITIONS COMPRISING UROLITHIN COMPOUNDS
#46METHODS OF IMPROVING NEURODEGENERATIVE DISORDERS BY TARGETED DELIVERY OF THERAPEUTIC AGENTS
#47CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#48MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS
#49Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
#50IMMUNOISOLATION DEVICE
#51DELIVERY METHODS FOR OMEGA-3'S AND COMPOSITIONS FOR VITAMINS AND MINERALS USED TO ENHANCE VISUAL ACUITY AND MENTAL DEVELOPMENT IN THE HUMAN BODY
#52PREBIOTIC FORMULATIONS
#53Inhalable Cannabinoid Formulations
#54SYSTEM AND METHOD FOR AEROBIC RESPIRATORY TREATMENT
#55COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING MATERIALS FOR FOLLICULAR DELIVERY
#56FORMULATIONS OF VILOXAZINE
#57METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOF
#58MODIFIED RELEASE FORMULATION
#59A COMPOSITON COMPRISING MICROCAPSULES
#60Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#61A PHARMACEUTICAL COMPOSITION IN ORAL DOSAGE FORM
#62Method for therapeutic treatment of rosacea
#63Process to enhance the bioactivity of Ashwagandha extracts
#64ENTERIC-COATED GRANULAR COMPOSITION COMPRISING INGREDIENTS DERIVED FROM BEE VENOM AND LACTIC ACID BACTERIA
#65COMPOSITION COMPRISING SAFRANAL AND PROBIOTICS
#66ENCAPSULATED PANCREATIC ISLET
#67A STABLE FOOD-GRADE MICROCAPSULE FOR THE DELIVERY OF UNSTABLE AND FOOD-INCOMPATIBLE ACTIVE INGREDIENTS TO FOOD PRODUCTS
#68COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING ANTIBIOTIC INDUCED PATHOLOGIES USING PROBIOTICS IN THE BIOFILM STATE
#69CELL CAPSULATING LAYER, CAPSULATED CELLS, CELL CAPSULATING COMPOSITION AND PREPARATION METHOD THEREFOR
#70Method for treatment of rosacea
#71VASODILATOR COMPOSITION, VASODILATOR COMPOSITION KIT, PHARMACEUTICAL COMPOSITION FOR DISEASE CAUSED BY VASCULAR STENOSIS OR VASCULAR OCCLUSIVE DISORDER, AND PHARMACEUTICAL COMPOSITION KIT FOR DISEASE CAUSED BY VASCULAR STENOSIS OR VASCULAR OCCLUSIVE DISORDER
#72Enriched Withania somnifera Based Dietary Composition and a Method Thereof
#73SOLID ORAL FORMULATION OF UTIDELONE
#74Multisomes: encapsulated droplet networks
#75PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#76INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELS
#77PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#78MICROPARTICLE FOR DRUG LOADING, DRUG LOADING MICROPARTICLE, PARTICLE CONTAINING TUBE, AND IMPLANTATION SYSTEM FOR MICROPARTICLE
#79HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
#80BACTERIAL MEMBRANE VESICLES, AND SEPARATION AND PREPARATION SYSTEM AND METHOD THEREFOR
#81METHOD FOR LONG-TERM TREATMENT OF ROSACEA
#82COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING MATERIALS FOR FOLLICULAR DELIVERY
#83POLYPEPTIDE FORMULATIONS
#84Compositions comprising urolithin compounds
#85SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#86Microsphere formulations comprising lurasidone and methods for making and using the same
#87PEPTOID-PEPTIDE HYBRID, NMEG-aCGRP, AND ITS USE IN CARDIOVASCULAR DISEASES
#88Surface Modified Gas Vesicles, Preparation and Applications thereof
#89Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#90PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
#91VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES
#92CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT
#93Method for treatment of rosacea
#94Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#95CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#96Encapsulated gas or partial vacuum CT contrast material
#97Particulate coated hydrogel microparticles
#98EXPANDABLE MICROCAPSULE
#99COMPOUNDS FOR PRENATAL TREATMENT COMPRISIING A NATAL VITAMIN AND ASPIRIN AND METHOD FOR MAKING AND USING THE SAME
#100PHARMACEUTICAL COMPOSITION CONTAINING TAMSULOSIN HYDROCHLORIDE WITH EXCELLENT ACID RESISTANCE AND PREPARATION METHOD THEREFOR
#101BLOOD-BRAIN BARRIER PERMEABLE PEPTIDE
#102Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
#103COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
#104Tunable process for silica capsules/spheres preparation and their use
#105Cannabinoid compositions for virtual and augmented reality experiences
#106MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS
#107CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#108Applying Fluoride for Treating or Preventing Viral Infection Including SARS-CoV-2
#109LIQUID DOSAGE FORMS OF SODIUM NAPROXEN
#110MULTISTAGE DELIVERY OF ACTIVE AGENTS
#111Method Of Treating Inflammation
#112DELIVERY METHODS FOR OMEGA-3'S AND COMPOSITIONS FOR VITAMINS AND MINERALS USED TO ENHANCE VISUAL ACUITY AND MENTAL DEVELOPMENT IN THE HUMAN BODY
#113Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#114Colon lavage system
#115PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER
#116COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS
#117CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#118ABSORBENT ARTICLE
#119DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
#120Method for treatment of rosacea in patients aged 65 years and older
#121Purified exosome products, method of making, and methods of using
#122FORMULATION HAVING IMPROVED PH-DEPENDENT DRUG-RELEASE CHARACTERISTICS CONTAINING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#123Immunoisolation device
#124Method for providing early onset of action in the treatment of rosacea
#125MODIFIED-RELEASE TIOPRONIN COMPOSITIONS, KITS AND METHODS FOR TREATING CYSTINURIA AND RELATED DISORDERS
#126SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING
#127Process to enhance the bioactivity of Ashwagandha extracts
#128Prebiotic formulations
#129MODIFIED RELEASE FORMULATION
#130CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#131METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#132USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#133Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#134Pharmaceutical active-containing film delivery device for oral transmucosal administration
#135Ocular inserts comprising a covalently linked steroid dimer
#136Alginate microcapsules for cell encapsulation and, manufacturing method therefor
#137COMPOSITIONS AND METHODS OF DETECTING AND TREATING ALZHEIMER'S DISEASE
#138FORMULATIONS CONTAINING MUCIN-AFFECTING PROTEASES
#139Drug-containing capsule, and component for air treatment device
#140Compositions and methods comprising energy absorbing materials for follicular delivery
#141PROBIOTIC RECOLONISATION THERAPY
#142A LIPID NANOPARTICLE COMPOSITION AND A PHARMACEUTICAL COMPOSITION FOR TREATING A HEMATOPROLIFERATIVE DISORDER
#143Compositions
#144Smart broadcast device
#145ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#146TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#147Compositions comprising urolithin compounds
#148USE OF CXCL12 TO PROMOTE SURVIVAL, FUNCTION, AND IMMUNOISOLATION OF STEM CELL-DERIVED BETA CELLS
#149APPLICATION OF PHARMACEUTICAL COMPOSITION IN REGULATION OF FIBROBLAST GROWTH
#150RISPERIDONE-CONTAINING MICROCAPSULE, METHOD FOR PREPARING SAME AND RELEASE CONTROL METHOD
#151External skin preparation comprising a core-shell structure
#152TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#153TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#154METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOF
#155Method for long-term treatment of rosacea
#156Method for treatment of rosacea in patients aged 65 years and older
#157Method for providing early onset of action in the treatment of rosacea
#158Method for therapeutic treatment of rosacea
#159Method of administering amantadine prior to a sleep period
#160Topical antiviral formulations and methods of using the same
#161TARGETED SYNBIOTIC THERAPY FOR DYSBIOSIS-RELATED INTESTINAL AND EXTRA-INTESTINAL DISORDERS
#162TARGETED SYNBIOTIC THERAPY FOR DYSBIOSIS-RELATED INTESTINAL AND EXTRA-INTESTINAL DISORDERS
#163Multisomes: encapsulated droplet networks
#164SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#165Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitor
#166Colon lavage system
#167Methods and devices for preparation of ultrasound contrast agents
#168COMPOSITIONS COMPRISING BACTERIAL STRAINS
#169Compositions and methods for treating multiple sclerosis
#170High capacity diketopiperazine microparticles and methods
#171CANNABINOID-INFUSED TRANSPARENT HYDROGEL SKIN PATCH
#172Dexamethasone prodrug compositions and uses thereof
#173Dexamethasone prodrug compositions and uses thereof
#174MICROCAPSULES CONTAINING LIVE MICROORGANISMS AND USE THEREOF
#175Smart broadcast device
#176FORMULATION COMPRISING EXTRACELLULAR VESICLES, METHOD FOR PRODUCING THE SAME, AND USES THEREOF
#177ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#178Treating pain in patients with hepatic impairment
#179EXTENDED-RELEASE TOPIRAMATE CAPSULES
#180SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS
#181TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#182Compositions and uses thereof for treating inflammatory diseases and probiotic compositions
#183Powdered formulations of cromolyn sodium and alpha-lactose
#184PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS
#185ORAL PHARMACEUTICAL COMPOSITION
#186Methods and devices for preparation of ultrasound contrast agents
#187TREATMENT OF FISH POPULATIONS WITH LUFENURON
#188Tamper resistant oral opioid agonist formulations
#189Controlled release pharmaceutical compositions comprising a fumaric acid ester
#190High capacity diketopiperazine microparticles and methods
#191Lactobacillus supplement for promoting gastric and immune health
#192PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER
#193Pharmaceutical Compositions for the Deterrence and/or Prevention of Abuse
#194Method for preparing microcapsules and microparticles of controlled size
#195Delayed release cysteamine bead formulation, and methods of making and using same
#196Probiotic recolonisation therapy
#197PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
#198Method of treating inflammation
#199Glass formulations and uses thereof
#200Particle containing at least a volatile substance and process for its preparation
#201CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#202Esomeprazole-containing complex capsule and preparation method therefor
#203Dexamethasone prodrug compositions and uses thereof
#204Formulation having improved pH-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
#205PD-1 SPECIFIC APTAMERS
#206Developable hyaluronic acid microspherical embolic agent, preparation method and use thereof
#207Compositions of food allergens
#208Compositions comprising proanthocyanidins and oenothein B
#209Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#210Use of reservatrol for the treatment of non-alcoholic fatty liver disease (NAFLD)
#211FORMULATIONS OF VILOXAZINE
#212CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#213PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS
#214Calcitonin Mimetics for Treating Diseases and Disorders
#215Compounds for prenatal treatment comprising a natal vitamin and aspirin and methods for making and using the same
#216BONE REGENERATION PROMOTING COMPOSITION AND BONE REGENERATION PROMOTING APPARATUS
#217Glass Composites for Tissue Augmentation, Biomedical and Cosmetic Applications
#218Controlled release pharmaceutical compositions comprising a fumaric acid ester
#219TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#220MULTISTAGE DELIVERY OF ACTIVE AGENTS
#221CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#222CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#223CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#224Oral complex preparation comprising fat-soluble drug and solid preparation coated with oil-proof material
#225High capacity diketopiperazine microparticles and methods
#226Method of production of inhalable composite particles using a three-fluid nozzle
#227USE OF TRIACETYL-3-HYDROXYPHENYLADENOSINE IN PREPARING PHARMACEUTICALS FOR TREATMENT OF ATHEROSCLEROSIS
#228PHARMACOKINETICS OF S-ADENOSYLMETHIONINE FORMULATIONS
#229TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#230RISPERIDONE-CONTAINING MICROCAPSULE, METHOD FOR PREPARING SAME AND RELEASE CONTROL METHOD
#231Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#232CONTROLLED RELEASE HYDROCODONE FORMULATIONS
#233MICROCAPSULES CONTAINING AN OXIDIZABLE ACTIVE, AND A PROCESS FOR PREPARING THE SAME
#234Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient
#235Compositions
#236System and method for synthesis of DNA particles and use thereof
#237Compositions comprising bacterial strains
#238Formulation comprising extracellular vesicles, method for producing the same, and uses thereof
#239Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#240PRODUCT AND METHOD FOR TREATMENT OF BIOFILM, INCLUDING CONTROL OF SUBSTRATE COLONIZATION AND TREATMENT OF INFECTION
#241COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING COMPOUNDS FOR FOLLICULAR DELIVERY
#242Probiotic recolonisation therapy
#243PEPTIDES WITH ANTI-ANGIOGENIC, ANTI-LYMPHANGIOGENIC, AND ANTI-EDEMIC PROPERTIES AND NANOPARTICLE FORMULATIONS
#244Treating pain in patients with hepatic impairment
#245Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
#246ETHER CELLULOSE DERIVATIVE MICROPARTICLE
#247MICROBUBBLES AND THEIR GENERATION
#248CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#249Immunoisolation device
#250Method of treating inflammation
#251MEDICAL PRODUCT AND METHOD FOR ELIMINATING SYMPTOMS OF NICOTINE WITHDRAWAL
#252Prebiotic composition and its methods of production
#253Liquid dosage forms of sodium naproxen
#254COMPOSITIONS FOR TREATING LUNG INFECTIONS BY AIRWAY ADMINISTRATION
#255Compositions and methods for treating multiple sclerosis
#256CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#257Process for making tablet using radiofrequency and lossy coated particles
#258Compositions comprising urolithin compounds
#259METHOD FOR TREATING INTESTINAL FIBROSIS
#260Sialylation-increasing therapies for diseases associated with oxidative stress
#261Encapsulation
#262Composition and method for treatment of metabolic disorders
#263PROTOCOL FOR HEALTH REHABILITATION
#264Topical antiviral formulations and methods of using the same
#265GAMMA-HYDROXYBUTYRIC ACID GRANULES
#266MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#267Composition and methods of screening
#268Instrument for skin treatment
#269Manufacture of pharmaceutical compositions
#270NON-AQUEOUS DELTA9-TETRAHYDROCANNABINOL ORAL LIQUID FORMULATIONS
#271METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#272Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
#273Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers
#274Delayed release pharmaceutical formulation and methods of making and using same
#275TARGETED SYNBIOTIC THERAPY FOR DYSBIOSIS-RELATED INTESTINAL AND EXTRA-INTESTINAL DISORDERS
#276CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#277COMPOSITIONS AND METHODS FOR PREVENTING COLORECTAL CANCER
#278TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#279Extended-release topiramate capsules
#280Multimodal antimicrobial therapy
#281Tamper resistant oral opioid agonist formulations
#282ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#283CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#284RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERY
#285Mebendazole polymorph for treatment and prevention of tumors
#286Albumin nanosphere preparations to control bleeding from surgical operations
#287Prebiotic formulations
#288Implantable medical devices having double walled microspheres
#289Glass composites for tissue augmentation, biomedical and cosmetic applications
#290Process for Making Tablet Using Radiofrequency and Lossy Coated Particles
#291Process to enhance the bioactivity of Ashwagandha extracts
#292METHODS AND DEVICES FOR PREPARATION OF ULTRASOUND CONTRAST AGENTS
#293DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#294DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#295DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#296Solid pharmaceutical preparation containing levothyroxine
#297Method of treating inflammation
#298DRUG DELIVERY FABRIC HAVING DRUG-CONTAINING LAYER
#299Method of making particles for use in a pharmaceutical composition
#300Formulations of viloxazine